You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Amgen Inc. operates several primary product lines including hematology, oncology, bone health, cardiovascular, nephrology, and inflammation products. Flagship products include Enbrel, Neulasta, Prolia, Xgeva, Aranesp, and Repatha. |
Business Models for Each Product Line |
Amgen generates revenue primarily through the sale of its pharmaceutical products across various therapeutic areas. The major expense categories include research and development costs, manufacturing expenses, and marketing and administrative costs. They utilize a combination of direct sales and partnerships for distribution. |
Future Opportunities for Growth |
Amgen has opportunities for growth through expanding their biosimilar product line, launching new therapies from their pipeline, enhancing their presence in emerging markets, and investing in innovative biotechnologies and collaborations. |
Potential Major Risks |
Potential risks include generic competition, regulatory changes, patent expirations, and pricing pressures in various markets. Additionally, rigorous R&D demands introduce the risk of failed trials and high associated costs. |
Learn More about Amgen Inc.:
Company Insights by Algobear (ChatGPT);
Tell me more about Amgen Inc.'s latest earnings (AMGN:Nasdaq)
Who are some of Amgen Inc.'s competitors? (AMGN:Nasdaq)
Are analysts bullish on Amgen Inc.? Please show it in a table format. (AMGN:Nasdaq)
Also read:
https://finance.yahoo.com/AMGN/profile
Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | PEG Ratio (5yr expected) | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Quarterly Earnings Growth | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
148.96 B | 148960000000.0 | 148.96 | 197.09 B | 197090000000.0 | 197.09 | 36.68 | 13.33 | 0.94 | 4.49 | 25.35 | 5.9 | 14.76 | 12.24% | 51.81% | 6.40% | 67.55% | 33.42 B | 33420000000.0 | 33.42 | 10.90% | 15.16 B | 15160000000.0 | 15.16 | 7.57 | -18.30% | 11.97 B | 11970000000.0 | 11.97 | 60.88 B | 60880000000.0 | 60.88 | 10.3589 | 1.26 | 11.49 B | 11490000000.0 | 11.49 | 13.73 B | 13730000000.0 | 13.73 | 0.22% | 81.93% |
source:https://finance.yahoo.com/AMGN/key-statistics
source:https://www.google.com/finance/quote/AMGN:NASDAQ
source:https://finance.yahoo.com/AMGN/analysis
source:https://finance.yahoo.com/AMGN/fair-value
source:https://www.nasdaq.com/market-activity/stocks/AMGN/price-earnings-peg-ratios
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 10.86% | 0.98% (283.6) | 12.16% (315) | 19.6% (335.88) | 19.6% (335.88) | 23.5% (346.85) | 23.5% (346.85) | 23.5% (346.85) |
Downside % (low) | 6.3% | 4.39% (268.5) | 4.79% (267.4) | 4.79% (267.4) | 9.81% (253.3) | 9.81% (253.3) | 24.62% (211.71) | 53.68% (130.09) |
Spread % | 4.56% | -3.41% | 7.38% | 14.81% | 9.79% | 13.7% | -1.11% | -30.17% |
AMGN's price used for computing the stats is 280.84 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | 0.36% | -0.64% | -3.52% | -10.67% | 3.21% | -14.47% | 3.28% | 10.84% | 71.68% |
Last Price | 280.84 | 280.84 | 280.84 | 280.84 | 280.84 | 280.84 | 280.84 | 280.84 | 280.84 |
Trend-Previous Close | 279.84 | 282.64 | 291.09 | 314.38 | 272.11 | 328.35 | 271.91 | 253.37 | 163.58 |
AMGN's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
returns:
-0.64%
(-8.35%),
p.close: 282.64
entry:
259.04,
exit:
263.04,
min.ret:
1.54%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.64%
(-8.69%),
p.close: 282.64
entry:
258.08,
exit:
258.08,
min.ret:
-0.0%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.64%
(-8.33%),
p.close: 282.64
entry:
259.09,
exit:
260.11,
min.ret:
0.4%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.64%
(-5.55%),
p.close: 282.64
entry:
266.95,
exit:
267.64,
min.ret:
0.26%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.64%
(-6.16%),
p.close: 282.64
entry:
265.23,
exit:
265.66,
min.ret:
0.16%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.64%
(-5.31%),
p.close: 282.64
entry:
267.64,
exit:
267.77,
min.ret:
0.05%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
returns:
-3.52%
(-11.18%),
p.close: 291.09
entry:
258.55,
exit:
262.18,
min.ret:
1.4%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
-3.52%
(-10.2%),
p.close: 291.09
entry:
261.39,
exit:
265.25,
min.ret:
1.47%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
BUY-APPROACHING
returns:
-3.52%
(-7.21%),
p.close: 291.09
entry:
270.11,
exit:
271.54,
min.ret:
0.53%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
BUY-APPROACHING
returns:
-3.52%
(-8.63%),
p.close: 291.09
entry:
265.97,
exit:
266.9,
min.ret:
0.35%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
BUY-APPROACHING
returns:
-3.52%
(-7.38%),
p.close: 291.09
entry:
269.6,
exit:
270.1,
min.ret:
0.19%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
BUY-APPROACHING
returns:
-10.67%
(-16.2%),
p.close: 314.38
entry:
263.46,
exit:
267.89,
min.ret:
1.68%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-ACTIVE
returns:
-10.67%
(-10.23%),
p.close: 314.38
entry:
282.22,
exit:
286.28,
min.ret:
1.44%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-10.67%
(-13.32%),
p.close: 314.38
entry:
272.51,
exit:
268.99,
min.ret:
-1.29%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-10.67%
(-10.79%),
p.close: 314.38
entry:
280.45,
exit:
279.3,
min.ret:
-0.41%
Using: 1M trend, 0 Days Left
|
AMGN's symbol current price is 280.84 (0.36%) as on . Yesterday's close was 279.84. It's return velocities are computed basis data from date .